Wird geladen...
It is time to move forward into the era of Theranostics
Radionuclide therapy, which until 15 years ago included only a few approved therapies, is gaining importance in the treatment of various malignancies. The future of oncology will not be limited to surgery, chemo-, antibody therapies or external radiation; it will include targeted therapy with radion...
Gespeichert in:
| Veröffentlicht in: | EJNMMI Res |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer Berlin Heidelberg
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5789121/ https://ncbi.nlm.nih.gov/pubmed/29380088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0364-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|